Table of Contents:
Wall Street and investor optimism
Post-election euphoria continues to affect US markets, with Wall Street opening higher after a week of record closings. Donald Trump’s victory in the recent presidential elections, combined with Republican control of the Senate, has fueled a climate of optimism among investors. This scenario led to a significant increase in stock prices, with the Dow Jones, the S&P 500 and the Nasdaq
recording significant gains.
The decisions of the Federal Reserve
Another factor contributing to this positive climate is the recent intervention of the Federal Reserve, which cut interest rates by 25 basis points, bringing them to 4.50%-4.75%. Analysts now turn their attention to the next Fed meeting, scheduled to take place a week before Christmas. According to the CME Group’s FedWatch Tool, there is a 68.8% chance that the Fed could decide on a further 25-basis point cut, which could further stimulate economic growth and support
stock markets.
The bond market and Veteran’s Day
Today, the United States celebrates Veteran’s Day, a day when the bond market remains closed and no significant macroeconomic data is expected. Despite this, the positive trend in the stock markets continues to dominate the economic news. The Dow Jones gained 245.22 points (+0.56%), the S&P 500 rose 19.80 points (+0.33%) and the Nasdaq registered an increase of 67.20 points (+0.35%). This positive momentum is a clear sign of investor confidence in the country’s economic future
.
Oil fluctuations and the influence of the dollar
However, not all the news is positive. The price of WTI oil at Nymex fell by 2.74%, falling to 68.45 dollars per barrel. This decline was influenced by the strengthening of the dollar and investor disappointment regarding economic stimulus plans in China. Energy market fluctuations can have significant repercussions on the global economy, making it essential to closely monitor
these dynamics.
PharmaNutra’s financial results
In a context of economic growth, it is interesting to note the financial results of PharmaNutra, which reported extraordinary performance in the first nine months of 2024. The company recorded a significant increase in revenues and profitability, thanks to strategic investments in research and development and the quality of its products. Vice President Roberto Lacorte emphasized that these results are the result of a long-term vision and a constant commitment to innovation
.
